82 related articles for article (PubMed ID: 16245205)
1. Epidermal growth factor receptor in glioblastoma.
Zawrocki A; Biernat W
Folia Neuropathol; 2005; 43(3):123-32. PubMed ID: 16245205
[TBL] [Abstract][Full Text] [Related]
2. Transactivation of the epidermal growth factor receptor by formylpeptide receptor exacerbates the malignant behavior of human glioblastoma cells.
Huang J; Hu J; Bian X; Chen K; Gong W; Dunlop NM; Howard OM; Wang JM
Cancer Res; 2007 Jun; 67(12):5906-13. PubMed ID: 17575160
[TBL] [Abstract][Full Text] [Related]
3. The EGFRvIII variant in glioblastoma multiforme.
Gan HK; Kaye AH; Luwor RB
J Clin Neurosci; 2009 Jun; 16(6):748-54. PubMed ID: 19324552
[TBL] [Abstract][Full Text] [Related]
4. Epidermal growth factor receptor targeting and challenges in glioblastoma.
Thorne AH; Zanca C; Furnari F
Neuro Oncol; 2016 Jul; 18(7):914-8. PubMed ID: 26755074
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic targeting of EGFR-activated metabolic pathways in glioblastoma.
Gao Q; Lei T; Ye F
Expert Opin Investig Drugs; 2013 Aug; 22(8):1023-40. PubMed ID: 23731170
[TBL] [Abstract][Full Text] [Related]
6. Maintenance of EGFR and EGFRvIII expressions in an in vivo and in vitro model of human glioblastoma multiforme.
Stockhausen MT; Broholm H; Villingshøj M; Kirchhoff M; Gerdes T; Kristoffersen K; Kosteljanetz M; Spang-Thomsen M; Poulsen HS
Exp Cell Res; 2011 Jul; 317(11):1513-26. PubMed ID: 21514294
[TBL] [Abstract][Full Text] [Related]
7. Old player, new partner: EGFRvIII and cytokine receptor signaling in glioblastoma.
Villa GR; Mischel PS
Nat Neurosci; 2016 May; 19(6):765-7. PubMed ID: 27227363
[No Abstract] [Full Text] [Related]
8. Herstatin, an autoinhibitor of the epidermal growth factor receptor family, blocks the intracranial growth of glioblastoma.
Staverosky JA; Muldoon LL; Guo S; Evans AJ; Neuwelt EA; Clinton GM
Clin Cancer Res; 2005 Jan; 11(1):335-40. PubMed ID: 15671564
[TBL] [Abstract][Full Text] [Related]
9. Age-dependent prognostic effects of EGFR/p53 alterations in glioblastoma: study on a prospective cohort of 140 uniformly treated adult patients.
Srividya MR; Thota B; Arivazhagan A; Thennarasu K; Balasubramaniam A; Chandramouli BA; Hegde AS; Santosh V
J Clin Pathol; 2010 Aug; 63(8):687-91. PubMed ID: 20702468
[TBL] [Abstract][Full Text] [Related]
10. Epidermal Growth Factor Receptor Expression May Correlate with Survival Through Clinical and Radiological Features of Aggressiveness in Glioblastoma Treated with Radiochemotherapy.
Tini P; Cerase A; Cevenini G; Carbone SF; Miracco C; Pirtoli L
Anticancer Res; 2015 Jul; 35(7):4117-24. PubMed ID: 26124364
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of EGFR Resistance in Glioblastoma.
Pan PC; Magge RS
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33187135
[TBL] [Abstract][Full Text] [Related]
12. MUC4 modulates human glioblastoma cell proliferation and invasion by upregulating EGFR expression.
Li W; Wu C; Yao Y; Dong B; Wei Z; Lv X; Zhang J; Xu Y
Neurosci Lett; 2014 Apr; 566():82-7. PubMed ID: 24582898
[TBL] [Abstract][Full Text] [Related]
13. Epidermal growth factor receptor transcriptionally up-regulates vascular endothelial growth factor expression in human glioblastoma cells via a pathway involving phosphatidylinositol 3'-kinase and distinct from that induced by hypoxia.
Maity A; Pore N; Lee J; Solomon D; O'Rourke DM
Cancer Res; 2000 Oct; 60(20):5879-86. PubMed ID: 11059786
[TBL] [Abstract][Full Text] [Related]
14. Complexities of lysophospholipid signalling in glioblastoma.
Ng W; Pébay A; Drummond K; Burgess A; Kaye AH; Morokoff A
J Clin Neurosci; 2014 Jun; 21(6):893-8. PubMed ID: 24746442
[TBL] [Abstract][Full Text] [Related]
15. Epidermal growth factor receptor: a re-emerging target in glioblastoma.
Hegi ME; Rajakannu P; Weller M
Curr Opin Neurol; 2012 Dec; 25(6):774-9. PubMed ID: 23007009
[TBL] [Abstract][Full Text] [Related]
16. Expression of cytoplasmic-domain substituted epidermal growth factor receptor inhibits tumorigenicity of EGFR-overexpressed human glioblastoma multiforme.
Liu KJ; Chen CT; Hu WS; Hung YM; Hsu CY; Chuang BF; Juang SH
Int J Oncol; 2004 Mar; 24(3):581-90. PubMed ID: 14767543
[TBL] [Abstract][Full Text] [Related]
17. FOXC2 often overexpressed in glioblastoma enhances proliferation and invasion in glioblastoma cells.
Li W; Fu X; Liu R; Wu C; Bai J; Xu Y; Zhao Y; Xu Y
Oncol Res; 2013; 21(2):111-20. PubMed ID: 24406047
[TBL] [Abstract][Full Text] [Related]
18. Detection of p53 mutations in proliferating vascular cells in glioblastoma multiforme.
Kawasoe T; Takeshima H; Yamashita S; Mizuguchi S; Fukushima T; Yokogami K; Yamasaki K
J Neurosurg; 2015 Feb; 122(2):317-23. PubMed ID: 25415071
[TBL] [Abstract][Full Text] [Related]
19. Small tyrosine kinase inhibitors interrupt EGFR signaling by interacting with erbB3 and erbB4 in glioblastoma cell lines.
Carrasco-García E; Saceda M; Grasso S; Rocamora-Reverte L; Conde M; Gómez-Martínez A; García-Morales P; Ferragut JA; Martínez-Lacaci I
Exp Cell Res; 2011 Jun; 317(10):1476-89. PubMed ID: 21439954
[TBL] [Abstract][Full Text] [Related]
20. Epidermal growth factor receptor as a therapeutic target in veterinary oncology.
Bergkvist GT; Yool DA
Vet Comp Oncol; 2011 Jun; 9(2):81-94. PubMed ID: 21569194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
